Cite
MLA Citation
Diana Treis et al.. “Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation.” JCO precision oncology, vol. 6, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100150610061.0x00001e